la esferocitosis hereditaria y su diagnostico en la practica clinica

181.— WlL1-1El~ M.C., JONES R,E., MC GEHEE R., MITCHENER J.S.,
SA\DLISKY \VR,. HESS C.E.: Splenec¡omy in hematologio disorders~
The ever-changing indlcations. Aun Surg, 1988; 207: 581—569.
liC.— ~\lL.LEv J.S.r Red cdl survival atudies In heredttary spherocytosis.
Clin Invear, 1970; 49: 666 -672.
183.~ ‘\ILLEY 1.5.: ileredi¡ary spherocytosis, ellip¡ocytosis and related di—
225
Sordera. Enr V3RAIN MC,, CARBONE PP.: Currení therapy ir, tIernatOlogy..Oncology
—3. Ontario, B.C. Decker Inc., 1988, 21— 23.
164..- \VLLLl.~j,iS J.W.: Pol~chrome stalning. En: WILLIAMS J.W., BEUTLER
E,, ERSLEV A., LICiITMAN M.A. (eda.).: Hema¡ology, 4’ edición.
New York, Mc Craw—l-illl, Inc., 1990; AZ: 1699—1770.
i$5. \VIN’KELMANN J.C., COSTA i’.Pt, FORCET 8.0.; Molecular cloning
of ihe cOÑA inc human skeleral muscle (3 spec¡rinr evidence for
tissue speciilc dlfierenílal processing of 3% apectrln p;e—mRNA.
t3looci. ¡988; 72 (Supple í» ISa.
186.- WOLi’E L.C., JOHN K.M., FALCONE J.C., BVRNE A.M., LUX S.E.:
A genetie defecí in the bindlng of protein 4.1 ¡o spectrln in a
klndred wich heredi¡ary spherocybosls. N Eng 3 Mcd, 1982; 307:
1367—1374.
187.— WOODS C.M., LAZARIDES E.: Degradation of unassembled alpha-and
beta—spectrin by dinlnc¡ intracellular pathwaysr regulailon of spec—
trirs topogenesís by beta—spectrin degiadation. dell, 1985; 40:
959 - 969
188.- YOUNG N., IIARRISON M., MOORE j., MORTIMER P., HUMPHRIES
R.K,: Direct demonstration of ¡he human parvQvlrus in eryíhrold
ptogenitor celia iniecíed in vitro, J Clin Invesí, 1984i 2024—2032.
189. — YOUNG N.: }Jemarc>logic and hemaropoieiic consequences of 619
parvovirus Infection. Semin llematol, 1988; 25; 159—172.
190.- ZACIICE lx, BOOCAERTS M.A,, HELLEMAÑS L., SÑAUWAERr J.:
A dveíse role of the spieen In hereditary spherocytosis: evidence by
the use of the use of the atomic (orce mícroscope. Br J Haenlarol,
1992; 80: 264- 265.